[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @NeerajResearch Dr. Neeraj Rajput Dr. Neeraj Rajput posts on X about matterhorn, promising, hub, ct the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::1156562720407187456/interactions)  - X Week XXX -XX% - X Months XXXXX +376% - X Year XXXXX +948% ### Mentions: X [#](/creator/twitter::1156562720407187456/posts_active)  ### Followers: XXX [#](/creator/twitter::1156562720407187456/followers)  - X Week XXX +1.60% - X Months XXX +47% - X Year XXX +30% ### CreatorRank: undefined [#](/creator/twitter::1156562720407187456/influencer_rank)  ### Social Influence [#](/creator/twitter::1156562720407187456/influence) --- **Social category influence** [travel destinations](/list/travel-destinations) XXXXX% [currencies](/list/currencies) XXXX% **Social topic influence** [matterhorn](/topic/matterhorn) #96, [promising](/topic/promising) 6.25%, [hub](/topic/hub) 6.25%, [ct](/topic/ct) 6.25%, [vienna](/topic/vienna) XXXX% **Top accounts mentioned or mentioned by** [@oncoalert](/creator/undefined) [@myesmo](/creator/undefined) [@sankardummy2s](/creator/undefined) [@drrishabhonco](/creator/undefined) [@thethakurforce](/creator/undefined) [@drdoc](/creator/undefined) [@benjohnson1112](/creator/undefined) [@jonathanloree](/creator/undefined) [@agenusbio](/creator/undefined) [@cdncancertrials](/creator/undefined) [@abouabdrahman0](/creator/undefined) [@thehindu](/creator/undefined) [@ermanakkus](/creator/undefined) [@brunolarvol](/creator/undefined) [@oncbrothers](/creator/undefined) [@arndtvogel](/creator/undefined) [@kchanchlani](/creator/undefined) [@niusanford](/creator/undefined) [@droz](/creator/undefined) [@huaweieurope](/creator/undefined) ### Top Social Posts [#](/creator/twitter::1156562720407187456/posts) --- Top posts by engagements in the last XX hours "@Benjohnson1112 @myESMO @jonathanloree @Agenus_Bio @CDNCancerTrials @OncoAlert Promising development 🚀 BOT/BAL showing durable immune activation even in MSS CRC is a big step forward. Looking forward to BATTMAN phase X outcomes and potential new options for refractory MSS mCRC. 🔬💪 #Immunotherapy #Oncology #ESMO25" [X Link](https://x.com/NeerajResearch/status/1982041981271621915) [@NeerajResearch](/creator/x/NeerajResearch) 2025-10-25T11:10Z XXX followers, XX engagements "@Erman_Akkus @OncoAlert @brunolarvol @OncBrothers Big news from #ESMO25 🚀 The MATTERHORN trial shows a significant OS benefit for Durvalumab + FLOT vs FLOT alone (HR 0.78; p=0.021) in upper GI cancer. Interesting note: even PD-L1 TAP X% subgroup shows a trend (HR 0.79). Immunotherapy keeps raising the bar in perioperative" [X Link](https://x.com/NeerajResearch/status/1979176083271438708) [@NeerajResearch](/creator/x/NeerajResearch) 2025-10-17T13:22Z XXX followers, XXX engagements "@ArndtVogel @myESMO #ESMO25: MATTERHORN trial 💥 Durvalumab + FLOT shows significant OS benefit (HR 0.78) in resectable gastric/GEJ cancer benefit seen across TAP levels. ➡ A step closer to a new perioperative SOC. #Oncology #GastricCancer @myesmo" [X Link](https://x.com/NeerajResearch/status/1979182929399157367) [@NeerajResearch](/creator/x/NeerajResearch) 2025-10-17T13:49Z XXX followers, XXX engagements "@Dr_Singularity New drug CBPD-409 degrades p300/CBP turns off androgen receptor signaling ✅ Shown to shrink tumors in CRPC models and well tolerated 🧬💊 #ProstateCancer #Oncology #CancerResearch @OncoAlert @myESMO" [X Link](https://x.com/NeerajResearch/status/1981021450870898818) [@NeerajResearch](/creator/x/NeerajResearch) 2025-10-22T15:34Z XXX followers, XX engagements "@drbennisahmed Important insight sleep apnea isnt just a comorbidity in HFpEF its a driver of structural and functional cardiac changes. Highlights the need for early screening and integrated cardio-respiratory management. 🫀💤 #CardioTwitter #HFpEF #SleepApnea #PARAGONHF" [X Link](https://x.com/NeerajResearch/status/1982042686283751837) [@NeerajResearch](/creator/x/NeerajResearch) 2025-10-25T11:12Z XXX followers, XX engagements "@escardio Looking forward to #EACVI2025 a hub for innovation in cardiovascular imaging Perfect opportunity to sharpen skills exchange insights and explore new frontiers in echo CT and MRI. 🫀📊 #CardioImaging #Vienna #EACVI" [X Link](https://x.com/NeerajResearch/status/1982042855314219497) [@NeerajResearch](/creator/x/NeerajResearch) 2025-10-25T11:13Z XXX followers, XX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@NeerajResearch Dr. Neeraj Rajput
Dr. Neeraj Rajput posts on X about matterhorn, promising, hub, ct the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXX -XX%
- X Months XXXXX +376%
- X Year XXXXX +948%
Mentions: X #
Followers: XXX #
- X Week XXX +1.60%
- X Months XXX +47%
- X Year XXX +30%
CreatorRank: undefined #
Social Influence #
Social category influence travel destinations XXXXX% currencies XXXX%
Social topic influence matterhorn #96, promising 6.25%, hub 6.25%, ct 6.25%, vienna XXXX%
Top accounts mentioned or mentioned by @oncoalert @myesmo @sankardummy2s @drrishabhonco @thethakurforce @drdoc @benjohnson1112 @jonathanloree @agenusbio @cdncancertrials @abouabdrahman0 @thehindu @ermanakkus @brunolarvol @oncbrothers @arndtvogel @kchanchlani @niusanford @droz @huaweieurope
Top Social Posts #
Top posts by engagements in the last XX hours
"@Benjohnson1112 @myESMO @jonathanloree @Agenus_Bio @CDNCancerTrials @OncoAlert Promising development 🚀 BOT/BAL showing durable immune activation even in MSS CRC is a big step forward. Looking forward to BATTMAN phase X outcomes and potential new options for refractory MSS mCRC. 🔬💪 #Immunotherapy #Oncology #ESMO25"
X Link @NeerajResearch 2025-10-25T11:10Z XXX followers, XX engagements
"@Erman_Akkus @OncoAlert @brunolarvol @OncBrothers Big news from #ESMO25 🚀 The MATTERHORN trial shows a significant OS benefit for Durvalumab + FLOT vs FLOT alone (HR 0.78; p=0.021) in upper GI cancer. Interesting note: even PD-L1 TAP X% subgroup shows a trend (HR 0.79). Immunotherapy keeps raising the bar in perioperative"
X Link @NeerajResearch 2025-10-17T13:22Z XXX followers, XXX engagements
"@ArndtVogel @myESMO #ESMO25: MATTERHORN trial 💥 Durvalumab + FLOT shows significant OS benefit (HR 0.78) in resectable gastric/GEJ cancer benefit seen across TAP levels. ➡ A step closer to a new perioperative SOC. #Oncology #GastricCancer @myesmo"
X Link @NeerajResearch 2025-10-17T13:49Z XXX followers, XXX engagements
"@Dr_Singularity New drug CBPD-409 degrades p300/CBP turns off androgen receptor signaling ✅ Shown to shrink tumors in CRPC models and well tolerated 🧬💊 #ProstateCancer #Oncology #CancerResearch @OncoAlert @myESMO"
X Link @NeerajResearch 2025-10-22T15:34Z XXX followers, XX engagements
"@drbennisahmed Important insight sleep apnea isnt just a comorbidity in HFpEF its a driver of structural and functional cardiac changes. Highlights the need for early screening and integrated cardio-respiratory management. 🫀💤 #CardioTwitter #HFpEF #SleepApnea #PARAGONHF"
X Link @NeerajResearch 2025-10-25T11:12Z XXX followers, XX engagements
"@escardio Looking forward to #EACVI2025 a hub for innovation in cardiovascular imaging Perfect opportunity to sharpen skills exchange insights and explore new frontiers in echo CT and MRI. 🫀📊 #CardioImaging #Vienna #EACVI"
X Link @NeerajResearch 2025-10-25T11:13Z XXX followers, XX engagements